Statutory scheme to control cost of branded medicines - consultation outcome
The government has published its response to the consultation on proposed changes to the statutory scheme that controls the prices of branded health service medicines.
The government made some changes to its proposals in response to issues and concerns raised by respondents. These are set out in the response document.
The finalised regulations, explanatory memorandum and impact assessment have been published.